Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
obesity drugs
Pharma
Novo, Lilly launches top Clarivate's 'Drugs to Watch' list
Novo's new insulin Awiqli and obesity prospect CagriSema are expected to rake in billions by 2030, according to Clarivate Analytics.
Zoey Becker
Jan 8, 2025 12:01pm
In weight loss trial, Lilly's Zepbound tops Novo's Wegovy
Dec 4, 2024 6:45am
As sales soared industrywide in Q3, Pfizer claimed No. 1 spot
Nov 25, 2024 3:00am
Lilly cuts revenue guidance as momentum stalls for tirzepatide
Oct 30, 2024 9:47am
UK warns GLP-1s not for 'body beautiful picture for Instagram'
Oct 25, 2024 8:20am
Weight loss drug maker Currax runs campaign against food noise
Sep 24, 2024 12:36pm
